Skip to main content

Healthy Adult Volunteers

10
Pipeline Programs
11
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
9
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

11 companies ranked by most advanced pipeline stage

Baxter
BaxterCosta Rica - Cartago
1 program
1
NaCl 0.9% in Glucose 5% with 40mEq PotassiumPhase 4
Biocorp
BiocorpFrance - Issoire
2 programs
2
D3S-001Phase 1
DR-0201Phase 11 trial
Active Trials
NCT06008652Completed10Est. Jul 2024
D3 Bio
D3 BioChina - Wuxi
1 program
1
D3S-001Phase 11 trial
Active Trials
NCT07093398Completed26Est. Nov 2025
Fortrea
FortreaDURHAM, NC
1 program
1
D3S-001Phase 1
Dren Bio
Dren BioCA - Foster City
1 program
1
DR-0201Phase 1
Daewon Pharma
Daewon PharmaKorea - Hwaseong
1 program
1
DW4421Phase 11 trial
Active Trials
NCT07382661Not Yet Recruiting36Est. Oct 2026
Dong-A ST
Dong-A STKorea - Seoul
1 program
1
G3041Phase 11 trial
Active Trials
NCT02058472Unknown30Est. May 2014
Visirna Therapeutics
Visirna TherapeuticsChina - Shanghai
1 program
1
VSA001 injectionPhase 1
Arrowhead Pharmaceuticals
1 program
1
VSA001 injectionPhase 11 trial
Active Trials
NCT05757596Completed24Est. Dec 2023
Bristol Myers Squibb
2 programs
BMS-986090PHASE_11 trial
BMS-986196PHASE_11 trial
Active Trials
NCT02079480Terminated130Est. Apr 2016
NCT06034899Withdrawn0Est. Nov 2023
Baxter International
1 program
NaCl 0.9% in Glucose 5% with 40mEq PotassiumPHASE_41 trial
Active Trials
NCT02822898Completed12Est. Aug 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Baxter InternationalNaCl 0.9% in Glucose 5% with 40mEq Potassium
Daewon PharmaDW4421
D3 BioD3S-001
BiocorpDR-0201
Bristol Myers SquibbBMS-986196
Arrowhead PharmaceuticalsVSA001 injection
Bristol Myers SquibbBMS-986090
Dong-A STG3041

Clinical Trials (8)

Total enrollment: 268 patients across 8 trials

NCT02822898Baxter InternationalNaCl 0.9% in Glucose 5% with 40mEq Potassium

Metabolism of Isotonic Versus Hypotonic Maintenance Solutions in Fasting Healthy Adults

Start: Jun 2016Est. completion: Aug 201612 patients
Phase 4Completed
NCT07382661Daewon PharmaDW4421

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Start: Feb 2026Est. completion: Oct 202636 patients
Phase 1Not Yet Recruiting
NCT07093398D3 BioD3S-001

A Phase 1 Study to Assess Food Effect on the Pharmacokinetics of D3S-001 in Healthy Adult Participants

Start: Jul 2025Est. completion: Nov 202526 patients
Phase 1Completed
NCT06008652BiocorpDR-0201

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DR-0201 in Healthy Adult Volunteers

Start: Nov 2023Est. completion: Jul 202410 patients
Phase 1Completed
NCT06034899Bristol Myers SquibbBMS-986196

A Study to Evaluate the Effect of Food on the Drug Levels of BMS-986196 in Healthy Adult Participants

Start: Sep 2023Est. completion: Nov 20230
Phase 1Withdrawn
NCT05757596Arrowhead PharmaceuticalsVSA001 injection

Study of VSA001 Injection in Chinese Healthy Adult Volunteers

Start: May 2023Est. completion: Dec 202324 patients
Phase 1Completed
NCT02079480Bristol Myers SquibbBMS-986090

Study to Evaluate the Safety, Tolerability, PK, and PD of BMS-986090 in Healthy Subjects

Start: May 2014Est. completion: Apr 2016130 patients
Phase 1Terminated
NCT02058472Dong-A STG3041

Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers

Start: Dec 2013Est. completion: May 201430 patients
Phase 1Unknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

11 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.